Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

altRX vs LifeMD

altRX and LifeMD both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
altRX logo

altRX

6.7
★★★☆☆3.4/5

Best for: semaglutide from $1149/month

Visit altRX →
VS
LifeMD logo

LifeMD

7.9
★★★★☆4/5

Best for: bloodwork inside the monthly price rather than billed on top

Visit LifeMD →

If you are choosing between altRX and LifeMD, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. LifeMD leads our six-part score, 7.9 to 6.7. One of the two has an FDA warning letter on record, covered below.

altRX vs LifeMD price

altRX and LifeMD start at the same figure, $149 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Semaglutide costs the same at both, $149 a month; tirzepatide is cheaper at altRX ($249 a month vs $349 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format, altRX prices compounded injections and brand-name pens, while LifeMD prices brand-name pens.

Where each one treats patients

altRX does not publish where it ships, and LifeMD lists 50 states.

Pricing

altRX

Compounded GLP-1 (semaglutide) starting tierCompounded
$149/mo
semaglutide
Compounded GLP-1/GIP (tirzepatide) starting tierCompounded
$249/mo
tirzepatide
Brand-name Ozempic®Brand-name
$1149/mo
semaglutide
Brand-name Mounjaro®Brand-name
$1249/mo
tirzepatide
Brand-name Zepbound®Brand-name
$1249/mo
tirzepatide
Brand-name Wegovy®Brand-name
$1579/mo
semaglutide

LifeMD

Program & provider feemonthly subscription
$149$75/mo
Save 50% right now
program-fee

First month $75, then $149/mo. Brand medication billed separately, or $0-$25/mo copay with commercial insurance.

Wegovy pill (oral semaglutide)Brand-name
$149/mo
wegovy

Medication only; plus the $149/mo program fee.

Wegovy penBrand-name
$199/mo
wegovy

Medication only (starting); plus the program fee. As low as $0-$25/mo with insurance.

Zepbound vialBrand-name
$349/mo
zepbound

Medication only; plus the $149/mo program fee.

What each price covers

Both prices cover the clinician visit.

altRX's price also covers the medication itself and shipping, which LifeMD does not claim.

LifeMD's price also covers lab work and coaching, which altRX does not claim.

altRX is silent on lab work and coaching.

LifeMD is silent on shipping.

That matters most for the drug: unless LifeMD confirms otherwise, budget for medication on top of its listed price.

altRX

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

LifeMD

Covered by the monthly price

Medication

Charged on top

Clinician visits

In the price

Shipping

Not stated

Lab work

In the price

Coaching

In the price

Where each one scores higher

Overall, LifeMD scores 7.9 and altRX 6.7 out of 10.

altRX is stronger on user experience (8.0 vs 3.0) and support (7.0 vs 5.5).

LifeMD is stronger on value (10.0 vs 5.0), trust & safety (6.0 vs 3.5) and accessibility (10.0 vs 5.0).

Effectiveness is within half a point.

How we score

altRX

6.7/10

Overall

LifeMD

7.9/10

Value25%

5.0A
vs
B
10.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

3.5A
vs
B
6.0

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
5.5

FDA warning letters

The FDA sent altRX a warning letter dated June 8, 2026 (letter 728236), and it is still open.

LifeMD has no FDA warning letter on record with us.

Features & Coverage

FeaturealtRXLifeMD
Starting Price$149/mo$149/mo
Features✓8 features0 features
States AvailableNot disclosed50
Compounded✓ Yes—
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted——
FDA Warning Letters1 letter✓None

About altRX

Compounded plans open at $149 for semaglutide and $249 for tirzepatide. Branded medication runs $1,149-$1,579, a figure that already contains the consult and the shipping. Every one of the four FDA-approved brands is stocked, Mounjaro, Ozempic, Wegovy and Zepbound, which no other entry in our directory matches. altRX works in both modalities, holds LegitScript certification, and prints the FDA compounded-medication disclaimer.

Read our full altRX review →

About LifeMD

LifeMD is a publicly traded telehealth seller. It carries brand-name GLP-1 medications only.

Read our full LifeMD review →

Pros & Cons

altRX

What we like

  • Tirzepatide costs $1249 a month, close to the $1249 median for brand-name tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and shipping

Watch-outs

  • Semaglutide costs $1149 a month, 16% above the $990 median for brand-name semaglutide across the sellers we compare
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • The FDA has issued altRX a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

LifeMD

What we like

  • Semaglutide costs $149 a month, 85% below the $990 median for brand-name semaglutide across the sellers we compare
  • Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
  • The monthly price includes clinician visits, lab work and coaching
  • Serves all 50 states
  • We found no FDA warning letters issued to LifeMD

Watch-outs

  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Not included in the monthly price: medication
  • Ask which pharmacy fills the prescription before you pay, so you can check its license

Our Verdict

Winner: LifeMD

LifeMD wins this one, 7.9 to 6.7, above all for bloodwork inside the monthly price rather than billed on top. altRX fits better if semaglutide from $1149/month is your priority.

Choose altRX if…

You want semaglutide from $1149/month and an opening price near $149 a month.

Choose LifeMD if…

You want bloodwork inside the monthly price rather than billed on top and an opening price near $149 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.6

Found

Tirzepatide at $169/month, 37% below the typical price

7.6

Breeze Meds

Knowing which pharmacy fills the vial: it names Belmar Pharmacy

7.7

HealthRX

Compounded semaglutide at $133/month

altRX vs LifeMD: FAQ

Neither on the entry price: altRX and LifeMD both start at about $149 a month. The difference is in what the price includes.
Yes, both sell semaglutide and tirzepatide.
altRX does not publish where it ships; LifeMD lists 50 states. Confirm your state before paying.
Both include the clinician visit. Only altRX includes the medication itself and shipping. Only LifeMD includes lab work and coaching.
altRX has an open FDA warning letter from June 8, 2026. LifeMD has none.
No. Neither altRX nor LifeMD pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.